› Forums › General Melanoma Community › June 13th Post-ASCO Teleconference
- This topic has 4 replies, 2 voices, and was last updated 14 years, 7 months ago by
Anonymous.
- Post
-
- June 1, 2011 at 5:12 pm
On Monday, June 13, 2011 from 2-3pm EDT, Dr. Lynn Schuchter will provide callers with an update from the American Society of Clinical Oncologists (ASCO) Annual Meeting in Chicago. The meeting will take place from June 3-7, 2011 and will include presentations on the latest information regarding research, treatment, diagnosis and prevention of melanoma. Please join us for this free teleconference aimed at providing patients and their loved ones with the most up-to-date news in melanoma. Registration is required.
On Monday, June 13, 2011 from 2-3pm EDT, Dr. Lynn Schuchter will provide callers with an update from the American Society of Clinical Oncologists (ASCO) Annual Meeting in Chicago. The meeting will take place from June 3-7, 2011 and will include presentations on the latest information regarding research, treatment, diagnosis and prevention of melanoma. Please join us for this free teleconference aimed at providing patients and their loved ones with the most up-to-date news in melanoma. Registration is required.
Dial-In Information:
Toll-Free Dial-in #: (877) 395-3025
Please dial in approximately 3-5 minutes early. You will be asked to record your first and last name, as well as your email address. You will then be placed in the call. Please make sure you record this information so we can track the number of participants we have on the line. A survey will be emailed to you after the call so we can gather your feedback.
Additional Information:
- Date of Call: 06/13/2011
- Time of Call: 14:00 Eastern Time
- Expected Duration: 60 minutes
- Topic: June 2011 ASCO Update
About the Speaker:
Dr. Lynn Schuchter is the University of Pennsylvania's C. Willard Robinson Professor of Hematology/Oncology, Chief of the Hematology/Oncology Division and Program Leader for Penn's Abramson Cancer Center's national Cancer Institute approved and funded Melanoma Research Program. She is a member of the board and the Scientific Advisory Committee for the Melanoma Research Foundation.
- Replies
- You must be logged in to reply to this topic.